glp-1 obesity market news today Home Delivery Injectables | Global Market Analysis Report GLP-1 Agonists Weight Loss Drugs
Description
Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)
The metabolite-gene layer revealed enrichment in galactose metabolism, platelet homeostasis, and nitric-oxide pathways
Addressing Patient-Related Barriers to GLP-1 Agonist Use
The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.
Enhanced with digestive enzymes
Just real, doctor-prescribed weight loss tailored to your body
